Loading clinical trials...
Loading clinical trials...
A Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of CORT118335 on Olanzapine-Induced Weight Gain in Healthy Subjects
Conditions
Interventions
Olanzapine
CORT118335
+1 more
Locations
1
United Kingdom
Quotient Sciences
Ruddington, Nottingham, United Kingdom
Start Date
April 1, 2019
Primary Completion Date
March 13, 2020
Completion Date
March 25, 2020
Last Updated
April 28, 2020
Lead Sponsor
Corcept Therapeutics
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions